MANUFACTURERS LIFE INSURANCE COMPANY, THE
InsurancePosition in AKTS — Aktis Oncology, Inc.
CIK 928047
TORONTO, A6
Position in AKTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$840,704
New position
Shares Held
46,993
first reported quarter
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026MANUFACTURERS LIFE INSURANCE COMPANY, THE holds $1,623,826,646 across 225 Biotechnology names. AKTS ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
408,931 | $315,956,447 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
553,243 | $247,045,129 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
662,365 | $219,156,707 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,977,080 | $146,817,960 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
535,062 | $101,153,471 | |
| 6 | ARGX |
Argenx SE
|
49,330 | $36,023,232 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
425,240 | $28,971,601 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
117,093 | $19,791,058 |
All Filings in AKTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $840,704 | 46,993 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||